Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


1 Eur J Gastroenterol Hepatol
1 Gastroenterology
1 Hepatology
1 J Gastroenterol
2 J Med Virol
2 J Viral Hepat
2 J Virol
2 Lancet Gastroenterol Hepatol
1 Transfusion
1 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Eur J Gastroenterol Hepatol

  1. ABDELAZIZ AO, Nabil MM, Abdelmaksoud AH, Shousha HI, et al
    Tumor behavior of hepatocellular carcinoma after hepatitis C treatment by direct-acting antivirals: comparative analysis with non-direct-acting antivirals-treated patients.
    Eur J Gastroenterol Hepatol. 2018 Sep 7. doi: 10.1097/MEG.0000000000001264.
    PubMed     Text format     Abstract available


    Re: Sofosbuvir, Velpatasvir, and Ribavirin in HCV.
    Gastroenterology. 2018 Sep 8. pii: S0016-5085(18)34936.
    PubMed     Text format    


  3. LIU X, Duan X, Holmes JA, Li W, et al
    A novel lncRNA regulates HCV infection through IFI6.
    Hepatology. 2018 Sep 10. doi: 10.1002/hep.30266.
    PubMed     Text format     Abstract available

    J Gastroenterol

  4. TAKEHARA T, Sakamoto N, Nishiguchi S, Ikeda F, et al
    Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial.
    J Gastroenterol. 2018 Sep 10. pii: 10.1007/s00535-018-1503.
    PubMed     Text format     Abstract available

    J Med Virol

  5. KHOSRAVI A, Karimi-Sari H, Abedi-Andani M, Behnava B, et al
    Acute Changes in Cardiac Function by Direct-acting Antiviral Therapy for Hepatitis C Infected Thalassemia Patients.
    J Med Virol. 2018 Sep 11. doi: 10.1002/jmv.25314.
    PubMed     Text format     Abstract available

  6. PENG H, Zhang L, Feng Y, Tang H, et al
    A cross-sectional serum investigation of a clustering HCV infection in Southwest China.
    J Med Virol. 2018 Sep 11. doi: 10.1002/jmv.25315.
    PubMed     Text format     Abstract available

    J Viral Hepat

  7. MACIAS J, Tellez F, Rivero-Juarez A, Palacios R, et al
    Early emergence of opportunistic infections after starting direct acting antiviral drugs in HIV/HCV coinfected patients.
    J Viral Hepat. 2018 Sep 10. doi: 10.1111/jvh.13003.
    PubMed     Text format     Abstract available

  8. IWAMOTO M, Calzia A, Dublineau A, Rouet F, et al
    Field evaluation of GeneXpert((R)) (Cepheid) HCV performance for RNA quantification in a Genotype 1 and 6 predominant patient population in Cambodia.
    J Viral Hepat. 2018 Sep 10. doi: 10.1111/jvh.13002.
    PubMed     Text format     Abstract available

    J Virol

  9. HUANG H, Zhang C, Wang B, Wang F, et al
    Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available

  10. RAMSAY JD, Evanoff R, Mealey RH
    Hepacivirus A Infection in Horses Defines Distinct Envelope Hypervariable Regions and Elucidates Potential Roles of Viral Strain and Adaptive Immune Status in Determining Envelope Diversity and Infection Outcome.
    J Virol. 2018;92.
    PubMed     Text format     Abstract available

    Lancet Gastroenterol Hepatol

  11. ESMAT G, El-Sayed MH, Hassany M, Doss W, et al
    One step closer to elimination of hepatitis C in Egypt.
    Lancet Gastroenterol Hepatol. 2018;3:665.
    PubMed     Text format    

  12. NELSON R
    New York State announces initiative to eliminate hepatitis C.
    Lancet Gastroenterol Hepatol. 2018;3:666.
    PubMed     Text format    


  13. SEHEULT JN, Triulzi DJ, Kaplan A
    Targeted prospective hepatitis C virus "lookback" program: is it an efficient and effective use of resources?
    Transfusion. 2018;58:2084-2085.
    PubMed     Text format    


  14. DI MAIRA T, Torregrosa A, Navarro V, Sanchez D, et al
    Liver Volume as a Predictor of Functional Improvement Post-DAA Treatment.
    Transplantation. 2018;102:e74-e81.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.